Ardelyx Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Ardelyx Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow JonesJul 18 15:13 ET

Express News | HC Wainwright & Co. Reiterates Buy on Ardelyx, Maintains $10 Price Target

BenzingaJul 18 15:02 ET

H.C. Wainwright Maintains Ardelyx(ARDX.US) With Buy Rating, Maintains Target Price $10

H.C. Wainwright analyst Ed Arce maintains $Ardelyx(ARDX.US)$ with a buy rating, and maintains the target price at $10.According to TipRanks data, the analyst has a success rate of 42.0% and a total

Moomoo NewsJul 18 11:31 ET · Ratings

Wedbush Maintains Ardelyx(ARDX.US) With Buy Rating, Cuts Target Price to $11

Wedbush analyst Laura Chico maintains $Ardelyx(ARDX.US)$ with a buy rating, and adjusts the target price from $15 to $11.According to TipRanks data, the analyst has a success rate of 49.4% and a

Moomoo NewsJul 18 09:31 ET · Ratings

Wedbush Sticks to Its Buy Rating for Ardelyx (ARDX)

TipRanksJul 18 08:45 ET

Ardelyx to Report Second Quarter 2024 Financial Results on August 1, 2024

WALTHAM, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet

GlobeNewswireJul 18 08:00 ET